Literature DB >> 2215942

Reliability of NINCDS-ADRDA clinical criteria for the diagnosis of Alzheimer's disease.

O L Lopez1, A A Swihart, J T Becker, O M Reinmuth, C F Reynolds, D L Rezek, F L Daly.   

Abstract

Although the NINCDS-ADRDA Work Group has recently developed uniform clinical criteria for the diagnosis of Alzheimer's disease (AD), inter-rater reliability studies of these criteria are few. We report a study in which 2 neurologists and 2 psychiatrists independently reviewed clinical data abstracted from the records of 30 demented subjects and 10 nondemented control subjects participating in a longitudinal study of AD at the University of Pittsburgh. We recorded the clinical data on a standardized form; the subjects' identity and clinical and pathologic diagnoses were omitted. Each physician diagnosed each case according to the NINCDS-ADRDA criteria. We calculated the inter-rater agreement for all possible 2-way combinations of clinicians with the Kappa statistic, which ranged from 0.36 (fair agreement) to 0.65 (substantial agreement). We conclude that current NINCDS-ADRDA criteria enable moderate levels of agreement among clinicians in general.

Entities:  

Mesh:

Year:  1990        PMID: 2215942     DOI: 10.1212/wnl.40.10.1517

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  Overview and findings from the religious orders study.

Authors:  David A Bennett; Julie A Schneider; Zoe Arvanitakis; Robert S Wilson
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

2.  Rate of early onset Alzheimer's disease: a systematic review and meta-analysis.

Authors:  Xi-Chen Zhu; Lan Tan; Hui-Fu Wang; Teng Jiang; Lei Cao; Chong Wang; Jun Wang; Chen-Chen Tan; Xiang-Fei Meng; Jin-Tai Yu
Journal:  Ann Transl Med       Date:  2015-03

3.  Neuropsychology of memory and SPECT in the diagnosis and staging of dementia of Alzheimer type.

Authors:  J D Greene; K Miles; J R Hodges
Journal:  J Neurol       Date:  1996-02       Impact factor: 4.849

Review 4.  Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?

Authors:  Robert E Becker; Nigel H Greig; Ezio Giacobini
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

Review 5.  Use of genetic variation as biomarkers for Alzheimer's disease.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

Review 6.  Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 7.  A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers.

Authors:  Emma Lawrence; Carolin Vegvari; Alison Ower; Christoforos Hadjichrysanthou; Frank De Wolf; Roy M Anderson
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

8.  Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease.

Authors:  Suk Ling Ma; Linda Chiu Wa Lam
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-08-31       Impact factor: 2.582

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.